Vident Investment Advisory’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Vident Investment Advisory’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,412	Closed	-$185K	–	1354
2021 Q4	$185K	Buy	+10,412	New	+$167K	﹤0.01%	1141
2021 Q3	–	Sell	-12,786	Closed	-$212K	–	1257
2021 Q2	$212K	Buy	+12,786	New	+$229K	0.01%	1034
2015 Q4	–	Sell	-59,100	Closed	-$738K	–	890
2015 Q3	$738K	Buy	59,100 +23,805	+67%	+$327K	0.1%	308
2015 Q2	$585K	Buy	35,295 +1,301	+4%	+$21K	0.08%	403
2015 Q1	$543K	Buy	33,994 +5,452	+19%	+$90.2K	0.11%	359
2014 Q4	$445K	Buy	+28,542	New	+$417K	0.15%	300

Other funds holding NXGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vident Investment Advisory's NXGN Position: Q1 2022 in Review

Vident Investment Advisory sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q1 2022, closing a stake of 10,412 shares — an estimated $185K sold.

Vident Investment Advisory first reported a position in NXGN in Q4 2014 and held it in 6 quarters. The position peaked at $738K in Q3 2015. 197 funds tracked by Wall St. Rank hold NXGN as of Q1 2022.

Vident Investment Advisory reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Vident Investment Advisory sold 10,412 NextGen Healthcare, Inc. Common Stock shares in Q1 2022, an estimated $185K.
Vident Investment Advisory first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2014 and held it in 6 quarters.
Vident Investment Advisory's NextGen Healthcare, Inc. Common Stock position peaked at $738K in Q3 2015.
197 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2022.

Based on Vident Investment Advisory's 13F filing for Q1 2022, filed 16 May 2022.